Patents by Inventor Kenji Osawa
Kenji Osawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11447554Abstract: This application provides: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition comprising the antibody, for treating and/or preventing ectopic ossification and/or bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).Type: GrantFiled: October 26, 2021Date of Patent: September 20, 2022Assignees: Saitama Medical University, Daiichi Sankyo Company, LimitedInventors: Takenobu Katagiri, Kenji Osawa, Sho Tsukamoto, Shinnosuke Tsuji, Yoshirou Kawaguchi, Kensuke Nakamura
-
Patent number: 11312776Abstract: This application provides: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition comprising the antibody, for treating and/or preventing ectopic ossification and/or bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).Type: GrantFiled: August 19, 2019Date of Patent: April 26, 2022Assignees: Saitama Medical University, Daiichi Sankyo Company, LimitedInventors: Takenobu Katagiri, Kenji Osawa, Sho Tsukamoto, Shinnosuke Tsuji, Yoshirou Kawaguchi, Kensuke Nakamura
-
Publication number: 20220041738Abstract: This application provides: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition comprising the antibody, for treating and/or preventing ectopic ossification and/or bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).Type: ApplicationFiled: October 26, 2021Publication date: February 10, 2022Applicants: Saitama Medical University, Daiichi Sankyo Company, LimitedInventors: Takenobu KATAGIRI, Kenji OSAWA, Sho TSUKAMOTO, Shinnosuke TSUJI, Yoshirou KAWAGUCHI, Kensuke NAKAMURA
-
Patent number: 10846825Abstract: A display control apparatus enabling a desired item to be displayed with excellent visibility by means of a simple operation is provided. An interface 1 of a terminal apparatus SV acquires associated information in which an orientation of display on a display D, a moving direction of an operation position to a touch panel TP, and a display state on the display D controlled by movement of the operation position are associated with each other. The interface 1 also acquires direction information indicating the moving direction of the operation position. A control unit 3 controls the display state on the display D in accordance with the orientation of the display and the moving direction indicated by the direction information based on the associated information.Type: GrantFiled: March 31, 2015Date of Patent: November 24, 2020Assignee: PIONEER CORPORATIONInventor: Kenji Osawa
-
Publication number: 20200002427Abstract: This application provides: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition comprising the antibody, for treating and/or preventing ectopic ossification and/or bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).Type: ApplicationFiled: August 19, 2019Publication date: January 2, 2020Applicants: SAITAMA MEDICAL UNIVERSITY, DAIICHI SANKYO COMPANY, LIMITEDInventors: TAKENOBU KATAGIRI, KENJI OSAWA, SHO TSUKAMOTO, SHINNOSUKE TSUJI, YOSHIROU KAWAGUCHI, KENSUKE NAKAMURA
-
Patent number: 10428148Abstract: This application provides: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition comprising the antibody, for treating and/or preventing ectopic ossification and/or bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).Type: GrantFiled: January 29, 2016Date of Patent: October 1, 2019Assignees: Saitama Medical University, Daiichi Sankyo Company, limitedInventors: Takenobu Katagiri, Kenji Osawa, Sho Tsukamoto, Shinnosuke Tsuji, Yoshirou Kawaguchi, Kensuke Nakamura
-
Publication number: 20180118835Abstract: This application provides: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition comprising the antibody, for treating and/or preventing ectopic ossification and/or bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).Type: ApplicationFiled: January 29, 2016Publication date: May 3, 2018Applicants: Saitama Medical University, Daiichi Sankyo Company, LimitedInventors: Takenobu Katagiri, Kenji OSAWA, Sho TSUKAMOTO, Shinnosuke TSUJI, Yoshirou KAWAGUCHI, Kensuke NAKAMURA
-
Publication number: 20180068417Abstract: A display control apparatus enabling a desired item to be displayed with excellent visibility by means of a simple operation is provided. An interface 1 of a terminal apparatus SV acquires associated information in which an orientation of display on a display D, a moving direction of an operation position to a touch panel TP, and a display state on the display D controlled by movement of the operation position are associated with each other. The interface 1 also acquires direction information indicating the moving direction of the operation position. A control unit 3 controls the display state on the display D in accordance with the orientation of the display and the moving direction indicated by the direction information based on the associated information.Type: ApplicationFiled: March 31, 2015Publication date: March 8, 2018Inventor: Kenji OSAWA
-
Patent number: 9402407Abstract: A method for preparing a Eucalyptus extract which decreases the Eucalyptus-specific odor and obtains the effective ingredient in high purity and high yield as a physiologically-active ingredient. An essential oil constituent is removed from the Eucalyptus plant and the residue is extracted with water or an organic solvent aqueous solution. Next, the obtained extraction residue is further extracted with an organic solvent aqueous solution or an organic solvent, whereby Macrocarpal A, Macrocarpal B, and Macrocarpal C contained in the Eucalyptus as a physiological active substance are prepared in higher content than using conventional methods. Further, the extract has improved good taste, appearance, and other desirable properties.Type: GrantFiled: June 17, 2009Date of Patent: August 2, 2016Assignee: LOTTE CO., LTD.Inventors: Yuuichi Maeda, Atsushi Narise, Sanae Kikuchi, Kenji Osawa
-
Publication number: 20140228297Abstract: An object of the present invention is to provide a preventive agent for atopic dermatitis and food products containing the agent. The present inventors conducted extensive studies and, as the result, found that atopic dermatitis can be prevented by orally ingesting collagen. The present invention provides a preventive agent for atopic dermatitis comprising collagen and food products containing the preventive agent for atopic dermatitis.Type: ApplicationFiled: April 16, 2014Publication date: August 14, 2014Applicant: LOTTE CO., LTD.Inventors: Hiroaki HIGUCHI, Atsushi NARISE, Kenji OSAWA, Katsumasa SHIMIZU, Masanori ITO
-
Publication number: 20120253014Abstract: An object of the present invention is to provide a preventive agent for atopic dermatitis and food products containing the agent. The present inventors conducted extensive studies and, as the result, found that atopic dermatitis can be prevented by orally ingesting collagen. The present invention provides a preventive agent for atopic dermatitis comprising collagen and food products containing the preventive agent for atopic dermatitis.Type: ApplicationFiled: December 7, 2010Publication date: October 4, 2012Applicant: Lotte Company, Ltd.Inventors: Hiroaki Higuchi, Atsushi Narise, Kenji Osawa, Katsumasa Shimizu, Masanori Ito
-
Publication number: 20120100082Abstract: Provided is an oral composition having a tongue coating removing effect and a strong bad breath removing effect. An oral composition having a tongue coating removing action, characterized by containing an extract of eucalyptus, a plant of the Myrtaceae family, as an essential ingredient.Type: ApplicationFiled: April 23, 2010Publication date: April 26, 2012Inventors: Satoshi Shizukuishi, Muneo Tanaka, Katsumasa Shimizu, Kenji Osawa
-
Publication number: 20120015063Abstract: To provide a composition for treatment and/or prevention of skin disorder, intensive research has been conducted. As a result, a mangosteen (Garcinia mangostana L.) pericarp extract has been found to have a reducing effect on the skin disorder. The present invention provides a composition for treatment and/or prevention of skin disorder, the composition including a mangosteen pericarp extract.Type: ApplicationFiled: March 30, 2010Publication date: January 19, 2012Inventors: Hiroaki Higuchi, Reiko Kuroda, Atsushi Narise, Katsumasa Shimizu, Kenji Osawa, Yoshihiro Nomura
-
Publication number: 20110227234Abstract: A multifunction card device has an external connection terminal, an interface controller, a memory, and the security controller connected to the interface controller and the external connection terminal. The interface controller has a plurality of interface control modes, and controls an external-interface action and a memory interface action by the control mode according to the instruction from the outside. The external connection terminals have an individual terminal individualized for every interface control mode, and a communalized common terminal. A clock input terminal, a power supply terminal, and an earthing terminal are included in the common terminals. A data terminal, and a dedicated terminal of the security controller are included in the individual terminals. Partial communalization and individualization of an external connection terminal attain a guarantee of the reliability of an interface, and increase control of physical magnitude to some kinds of interface control modes.Type: ApplicationFiled: June 3, 2011Publication date: September 22, 2011Inventors: Hirotaka Nishizawa, Akira Higuchi, Kenji Osawa, Junichiro Osako, Tamaki Wada, Michiaki Sugiyama
-
Patent number: 7971791Abstract: A multifunction card device has an external connection terminal, an interface controller, a memory, and the security controller connected to the interface controller and the external connection terminal. The interface controller has a plurality of interface control modes, and controls an external-interface action and a memory interface action by the control mode according to the instruction from the outside. The external connection terminals have an individual terminal individualized for every interface control mode, and a communalized common terminal. A clock input terminal, a power supply terminal, and an earthing terminal are included in the common terminals. A data terminal, and a dedicated terminal of the security controller are included in the individual terminals. Partial communalization and individualization of an external connection terminal attain a guarantee of the reliability of an interface, and increase control of physical magnitude to some kinds of interface control modes.Type: GrantFiled: July 3, 2003Date of Patent: July 5, 2011Assignee: Renesas Electronics CorporationInventors: Hirotaka Nishizawa, Akira Higuchi, Kenji Osawa, Junichiro Osako, Tamaki Wada, Michiaki Sugiyama
-
Patent number: 7971793Abstract: The present invention provides a memory card equipped with an interface controller connected to external connecting terminals, a memory connected to the interface controller, and a security controller connected to the interface controller. A second external connecting terminal capable of supplying an operating power supply to the security controller is provided aside from a first external connecting terminal which supplies an operating power supply to the interface controller and the memory. An interface unit of the interface controller connected to the security controller receives the operating power supply from the second external connecting terminal and thereby enables a stop of the supply of the operating power supply from the first external connecting terminal. Even if the supply of the operating power supply to the interface controller is cut off, the output of the interface unit is not brought to an indefinite state.Type: GrantFiled: November 27, 2007Date of Patent: July 5, 2011Assignee: Renesas Electronics CorporationInventors: Hirotaka Nishizawa, Akira Higuchi, Kenji Osawa, Tamaki Wada, Michiaki Sugiyama, Junichiro Osako
-
Publication number: 20110135787Abstract: Provided are a deodorizing composition which contains a highly safe natural plant extract that can be used in foods without anxiety as an active ingredient, and has a high deodorization effect even under a neutral condition, and a food and drink article containing the deodorizing composition. The deodorizing composition is characterized by containing a plant belonging to the genus Rubus in the family Rosaceae and peroxidase.Type: ApplicationFiled: August 4, 2009Publication date: June 9, 2011Inventors: Takahito Takase, Atsushi Narise, Sanae Kikuchi, Kenji Osawa
-
Publication number: 20110129554Abstract: A method for preparing a Eucalyptus extract which decreases the Eucalyptus-specific odor and obtains the effective ingredient in high purity and high yield as a physiologically-active ingredient. An essential oil constituent is removed from the Eucalyptus plant and the residue is extracted with water or an organic solvent aqueous solution. Next, the obtained extraction residue is further extracted with an organic solvent aqueous solution or an organic solvent, whereby Macrocarpal A, Macrocarpal B, and Macrocarpal C contained in the Eucalyptus as a physiological active substance are prepared in higher content than using conventional methods. Further, the extract has improved good taste, appearance, and other desirable properties.Type: ApplicationFiled: June 17, 2009Publication date: June 2, 2011Applicant: LOTTE CO., LTD.Inventors: Yuuichi Maeda, Atsushi Narise, Sanae Kikuchi, Kenji Osawa
-
Patent number: 7946500Abstract: An antenna connection function for a noncontact interface is provided by suppressing a modification in a pin arrangement and a pin shape of a memory card that does not correspond to the noncontact interface. Two antenna connecting pins having the memory card are divided into two areas in which a size of one potential supply pin is the largest and used as a split pin arranged at intervals. Because a size of the two antenna connecting pins is at maximum as large as the size of the potential supply pin, the two antenna connecting pins are provided and the memory card that corresponds to the noncontact interface is obtained by devoting a pin area having the size of the one potential supply pin to the memory card that does not correspond to the noncontact interface. Accordingly, the pin area of the memory card that corresponds to the noncontact interface can be formed without departing from the pin area of the memory card that does not correspond to the noncontact interface.Type: GrantFiled: December 16, 2007Date of Patent: May 24, 2011Assignee: Renesas Electronics CorporationInventors: Hirotaka Nishizawa, Akira Higuchi, Kenji Osawa, Junichiro Osako, Tamaki Wada, Michiaki Sugiyama
-
Publication number: 20110076348Abstract: To provide a prophylactic and/or therapeutic agent for atopic dermatitis with minimal concerns of adverse drug reactions and high safety, various researches were conducted. As a result, it was found that an extract extracted from a mangosteen (Garcinia mangostana L.) peel with a polar solvent prevented or healed atopic dermatitis. That is, the present invention provides a prophylactic and/or therapeutic agent for atopic dermatitis comprising an extract extracted from a mangosteen peel with a polar solvent. Furthermore, the present invention provides a food containing the above-mentioned prophylactic and/or therapeutic agent for atopic dermatitis.Type: ApplicationFiled: May 19, 2009Publication date: March 31, 2011Inventors: Reiko Kuroda, Higuchi Hiroaki, Narise Atsushi, Katsumasa Shimizu, Kenji Osawa